Dirk Thye, Chief Executive Officer at Quince Therapeutics, Inc. (QNCX), bought 80,000 shares at $1.24 ($99K) on 2023-08-08, disclosed to the SEC on 2023-08-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |